from Sustainable Resources to novel marine nutraceuticals for the management of Metabolic Syndrome
SuReMetS develops novel marine ingredients from underutilised material from fisheries and microalgae targeting the management of metabolic syndrome (MetS). To utilise the marine biomasses in an economically viable manner, it is essential to find efficient ways to process the material to release valuable ingredients. One of the main goals of SuReMetS is to identify novel enzymes that can be used to process biomass with high efficiency at low temperatures. The second goal of the project is to extract value from marine resources by identifying novel marine ingredients. The potential beneficial human health effects of marine nutraceuticals are well established and include antioxidants, anti-inflammatory and antihypertensive properties amongst others. SuReMetS targets marine derived biofunctional ingredients with beneficial effects on biomarkers of metabolic syndrome, i.e., to lower the risk of heart disease, stroke, and type 2 diabetes. MetS involves a variety of conditions including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal serum cholesterol/triglyceride levels. The chronic and complex nature of MetS, makes it challenging to employ a single drug for long-term medication, hence the development of marine nutraceuticals represents a safer and better long-term option.
Link to the project HERE